Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibitionLei Gao, Liang Chen, Yong Hu et al.|Nature Communications|2019Cited by 68
Blocking interaction between SHP2 and PD‐1 denotes a novel opportunity for developing PD‐1 inhibitorsZhenzhen Fan, Liang Chen|EMBO Molecular Medicine|2020Cited by 65
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancerQian Zhou, Liang Chen, Wensheng Chen et al.|EMBO Molecular Medicine|2021Cited by 56
Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancerQian Zhou, Liang Chen, Wensheng Chen et al.|Theranostics|2021Cited by 30